Multiple Approaches for Individualized Fertility Protective Therapy in Cancer Patients

Table 1

Risk of ovarian toxicity of antineoplastic drugs.

High risk	Cyclophosphamide, ifosfamide, busulfan, mechlorethamine, melphalan
Intermediate risk	Doxorubicin, epirubicin, cisplatin, docetaxel, paclitaxel
Low risk	Vincristine, methotrexate, 5-fluorouracil, trastuzumab